tegafur has been researched along with Inflammation in 6 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 83 advanced gastric cancer patients receiving biweekly docetaxel/S-1 treatment (DS) were included in the study." | 1.38 | Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy. ( Akiyama, H; Endo, I; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Ono, HA; Oshima, T; Takagawa, R; Takahashi, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Kasuga, A | 1 |
| Okano, N | 1 |
| Naruge, D | 1 |
| Kitamura, H | 1 |
| Takasu, A | 1 |
| Nagashima, F | 1 |
| Furuse, J | 1 |
| Tanigawa, T | 1 |
| Miyamoto, Y | 1 |
| Abe, M | 1 |
| Hasuo, T | 1 |
| Doiguchi, M | 1 |
| Sakamoto, F | 1 |
| Chikama, T | 1 |
| Takahashi, N | 1 |
| Wakuta, M | 1 |
| Nishida, T | 1 |
| Kunisaki, C | 1 |
| Takahashi, M | 1 |
| Ono, HA | 1 |
| Oshima, T | 1 |
| Takagawa, R | 1 |
| Kimura, J | 1 |
| Kosaka, T | 1 |
| Makino, H | 1 |
| Akiyama, H | 1 |
| Endo, I | 1 |
| Hakoi, K | 1 |
| Hayashi, T | 1 |
| Ohmae, S | 1 |
| Besshi, K | 1 |
6 other studies available for tegafur and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disea | 2015 |
[A case of inflammatory carcinoma, well-controlled by chemotherapy, especially, vinorelbine, S-1 and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineop | 2009 |
Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1.
Topics: Aged; Antineoplastic Agents; Drug Combinations; Eye Diseases; Female; Humans; Inflammation; Male; Mi | 2009 |
Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; C-Reactive | 2012 |
[A 26-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Blood Chemical Analysis; Body Weight | 1996 |